Is it time to be overweight on pharma? | Tushar Bohra, MK Ventures

Tushar Bohra, Co-founder & Fund Manager at MK Ventures is selectively bullish on pharma companies after 6 years of neutral view. He is bullish on companies investing in Specialty businesses. According to him, large cap companies like Sun Pharma, Divis are doing very well. India business of companies is very strong across the board. So is it time for investors to be overweight on pharma stocks? Watch as he discusses with Ayesha Faridi and Nayantara Rai on ET NOW’s Closing Trades.#MKVentures #Pharmacompanies #PharmatradeRead More